Demand for Flexibility in Minimally Invasive Heart Surgeries Driving Aortic Cannula Systems Market: Fact.MR

Relatively higher risks of complications associated with cardiac surgical activities gain ground in the adoption of aortic cannula systems.

Fact.MR, Rockville MD: An ongoing report on the aortic cannula systems market published by market research company Fact.MR has projected the market to exhibit strong growth in 2021 and beyond. The COVID-19 pandemic has moderately impacted operations in the aortic cannula systems market owing to strict lockdown restrictions on production facilities, and postponed procedures for elective medical requirements. Also, restraints on domestic and international trade hurts supply chains. The market is expected to display a steady recovery through 2021, as healthcare resources previously tied up in pandemic management become available to patients.

According to a report by the Center for Disease Control, heart diseases are considered as the leading cause for death in multiple ethnic groups in the United States. As per CDC estimates, cardiovascular disease results in one death for every 36 seconds, which accounts for 1 in 4 deaths in the country. The resultant demand for heart surgery, and minimally invasive options are likely to generate interest and revenue opportunities for aortic cannula systems.

High levels of customization requirements in cardiac surgical procedures for positive outcomes is a key factor supporting flexibility in minimally invasive surgical options. Design innovations to improve ease of use and operational technology allows myriad surgical techniques and clinician preferences.

“Rapid growth in the geriatric population demographic has resulted in an increase in the number of hospitalization cases associated with cardiac conditions, which has played an essential role in the growing adoption of aortic cannulas globally. Furthermore, the rising number of surgeries, investments towards advancements in health care facilities, and government incentives are likely to propel developments in the global aortic cannulas market for the foreseeable future,” comments a Fact.MR analyst.

Request a report sample to gain detailed insights at

Key Takeaways from Fact.MR’s Aortic Cannula Systems Market

  • Silicone aortic cannulas to reflect higher growth rate owing to reduced risk of reaction from patients.
  • Hospital applications remain major revenue generators owing to easier access to capital and infrastructure.
  • United States holds major market share owing to vast geriatric population and favorable reimbursement policies.
  • India and China are fast growing markets owing to investments into healthcare research and a large patient pool.

Aortic Cannula Systems Market – Prominent Drivers

  • Poor lifestyle choices associated with higher incidences of cardiac issues generate lucrative opportunities.
  • High interest in minimally invasive surgery and faster recovery times support the use of aortic cannulas.
  • Tech advances to minimize back-bleed supports growth in the aortic cannula systems market.

Aortic Cannula Systems Market – Key Restraints

  • High costs associated with cardiac treatments and surgery is a major factor holding back adoption rates.
  • Strict and evolving regulations associated with aortic cannula production and development limits growth prospects.

Discover more about the aortic cannula systems market with figures data tables and table of contents. You can also find detailed market segmentation at

Competitive Landscape

Major players in the aortic cannula systems market include but are not limited to Braile Biomédica, Cardinal Health, CardioMed Supplies Inc., Edwards Lifesciences Corporation, LivaNova PLC, and Medidex.

Leading players in the aortic cannula market are displaying increased interest in the development and launch of new products, leveraging recent improvements in regulatory approval rates, supporting geographical expansion aims.

Paragonix Technologies announced the receipt of an FDA clearance for its SherpaPak Cardiac Transport System (CTS) with aortic root cannula aimed to be used used with pediatric donor hearts.

In June 2019, Edwards Lifesciences revealed its IntraClude Intra-Aortic Occlusion Device, a 3-lumen catheter for applications with its Edwards Introducer Sheath and EndoReturn arterial cannula.

Also, MC3 Cardiopulmonary announced the acquisition of surgical cannula assets from Terumo Corporation in addition to soft-flow arterial cannula offerings, focusing on heart and lung extracorporeal life support research.

More Insights on the Aortic Cannula Systems Market

In its latest report, Fact.MR offers unbiased analysis of the global aortic cannula systems market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product (plastic cannulas, silicone cannulas, and metal cannulas), application (thoracic aortic disease, surgical management of burn injuries, cardiac mechanical support, arterial-venous cannulation, and cardiopulmonary bypass), and end user (hospital, ambulatory surgery centers, and others) across seven regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa).

Request For No-Obligation Table Of Content

Explore Fact.MR’s Coverage on the Healthcare Domain

Micro-bypass Systems Market: A recent study by Fact.MR on the micro-bypass systems market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

High-flow Nasal Cannula Market: Fact.MR’s extensive coverage on the high-flow nasal cannula market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cough Systems Market: The global cough systems market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.  

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.    

Sudip Saha
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Back to news